Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1447 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Acromesomelic Dysplasia, Maroteaux Type | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| AMDM | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Acromesomelic dysplasia, Maroteaux type (AMDM; MIM 602875) is an autosomal recessive skeletal dysplasia caused by loss of function mutations in the natriuretic peptide receptor B gene (NPR2). Birth length and weight are normal in most infants but skeletal growth falls off sharply. By 1-2 years of age, diagnostic skeletal changes are present and consist of short and misshapen bones of the limbs and spine, and abnormal growth plates. Adult height is typically more than 5 SDs below the mean. In addition to short long bones other findings may include: a prominent forehead, a short nose, curved clavicles, joint laxity, lordosis, kyphosis, oval shaped vertebrae in infancy, bowed forearms with limited elbow extension, metaphyseal flaring of long bones, short and broad phalanges with cone shaped epiphyses and short nails. Natriuretic peptide receptor B (NPRB) is a transmembrane receptor. Its ligand is C-type natriuretic peptide. NPRB has guanylate cyclase activity and plays a major role via downstream signaling in skeletal growth and development. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| NPR2 | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 602875 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Skeletal Disorders | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.